Katsuya, Yuki http://orcid.org/0000-0002-2127-3601
Yoshida, Tatsuya
Takashima, Atsuo
Yonemori, Kan
Ohba, Akihiro
Yazaki, Shu
Yagishita, Shigehiro
Nakahama, Hiroko
Kobayashi, Osamu
Yanagida, Masatoshi
Irino, Yasuhiro
Hamada, Akinobu
Yamamoto, Noboru
Article History
Received: 12 November 2023
Accepted: 5 January 2024
First Online: 21 February 2024
Declarations
:
: The authors report the following conflicts of interest: YT Grants or contracts from AMGEN, AstraZeneca, Takeda, Daiichi Sankyo, Ono, MSD, Abbvie, Novartis, Chugai, Merck, Blueprint and BMS, Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from AstraZeneca, Takeda, Daiichi Sankyo, Boehringer-Ingelheim, TAIHO, Chugai, Novartis, Lilly, MSD, Ono, and BMS, Participation on a Data Safety Monitoring Board or Advisory Board from AstraZeneca, Novartis, AMGEN, MSD, and Chugai. AT Honaria from Lilly, Ono, Chugai pharma, Taiho, Takeda, Research funding from MSD, AstraZeneca, Amgen, Eisai, BMS, ONO. KY Advisory Board from Novartis, Eisai, AstraZeneca, Chugai, Takeda, Genmab, OncXerna. Research support (to institution) from MSD, Daiichi-Sankyo, AstraZeneca, Taiho, Pfizer, Novartis, Takeda, Chugai, Ono, Sanofi, Seattle genetics, Eisai, Eli Lilly, Genmab, Boehringer Ingelheim, Kyowa Hakko Kirin, Nihon Kayaku, Haihe. Honorarim for lecture from Pfizer, Eisai, AstraZeneca, Eli Lilly, Takeda, Chugai, Fuji Film Pharma, MSD, Boehringer Ingelheim、Ono, Daiichi-Sankyo, PDR pharma, Bayel. AO Grants or contracts from Ono and Daiichi Sankyo. Payment or honoraria for lectures, presentations, speaker bureaus, manuscript writing or educational events from Ono and Servier. AH Grants or contracts from Sysmex. YI and MY salaried employee of Sysmex Corporation. NY Research grants from Astellas, Chugai, Eisai, Taiho, BMS, Pfizer, Novartis, Eli Lilly, AbbVie, Daiichi-Sankyo, Bayer, Boehringer Ingelheim, Kyowa Kirin, Takeda, ONO, Janssen Pharma, MSD, MERCK, GSK, Sumitomo Pharma, Chiome Bioscience, Otsuka, Carna Biosciences, Genmab, Shionogi, TORAY, KAKEN, AstraZeneca, Cimic. Advisory role of Eisai, Takeda, Otsuka, Boehringer Ingelheim, Cimic, Chugai, Healios. Speakers bureaus from ONO, Chugai, Daiichi-Sankyo, Eisai. All other authors have declared no conflicts of interest.